Alkermes ALKS
NASDAQ ALKS
$46.17 +0.27 (+0.59%)
At close: Nov 9, 2026 · 4:00 PM EST

Alkermes (ALKS) Cost of Revenue (2010 - 2026)

Updated

Alkermes (ALKS) posted Cost of Revenue of $94.22 million for Q3 2026, up 82.6% from $51.59 million a year earlier but down 4.0% from the prior quarter.

Analysis

Alkermes (ALKS) Cost of Revenue (2010 - 2026) Analysis & Trends

For the trailing twelve months through Sep 30, 2026, Cost of Revenue at Alkermes was $300.12 million, up 41.3% year-over-year; for FY2025, it was $196.46 million, down 19.9% from FY2024.

  • Annual Cost of Revenue shows a five-year compound annual growth rate of 2.0% (FY2020 to FY2025).
  • In prior years, Alkermes' Cost of Revenue was $245.33 million in FY2024 (-3.0%), $253.04 million in FY2023 (+16.0%), $218.07 million in FY2022 (+10.5%) and $197.32 million in FY2021 (+10.7%).
  • Quarterly Cost of Revenue has run from a low of $46.21 million in Q4 2025 to a high of $98.11 million in Q2 2026 over five years.
  • On a year-over-year basis, Cost of Revenue has increased in each of the last three quarters, with growth averaging 14.4% over the last eight quarters.
  • The strongest year-over-year quarter for Cost of Revenue in the past five years was Q2 2026, with growth of 98.4%; the weakest was Q4 2025, with a decline of 25.6%.
  • According to Business Quant data, Cost of Revenue for the three prior quarters was $98.11 million (Q2 2026), $61.58 million (Q1 2026) and $46.21 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cost of Rev (Qtr)
1 Eli Lilly 1,261.99 Bn 1,235.61 Bn 20.46 Bn 3.93 Bn
2 Johnson & Johnson 678.93 Bn 598.79 Bn 17.30 Bn 8.10 Bn
3 AbbVie 518.29 Bn 486.30 Bn 13.12 Bn 4.29 Bn
4 Merck 365.98 Bn 328.92 Bn 13.19 Bn 4.89 Bn
5 Novartis Ag 316.85 Bn 290.09 Bn - -
6 Astrazeneca 293.40 Bn 267.29 Bn 13.26 Bn 2.95 Bn
7 Amgen 251.78 Bn 203.43 Bn 7.58 Bn 2.79 Bn
8 Gilead Sciences 210.61 Bn 185.71 Bn 6.73 Bn 1.57 Bn
9 Pfizer 166.87 Bn 114.23 Bn 12.56 Bn 4.03 Bn
10 Alkermes 7.77 Bn 5.26 Bn 385.91 Mn 94.22 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 94.22 Mn
Jun 30, 2026 98.11 Mn
Mar 31, 2026 61.58 Mn
Dec 31, 2025 46.21 Mn
Sep 30, 2025 51.59 Mn
Jun 30, 2025 49.46 Mn
Mar 31, 2025 49.20 Mn
Dec 31, 2024 62.12 Mn
Sep 30, 2024 63.10 Mn
Jun 30, 2024 61.47 Mn
Mar 31, 2024 58.64 Mn
Dec 31, 2023 70.13 Mn
Sep 30, 2023 61.50 Mn
Jun 30, 2023 63.25 Mn
Mar 31, 2023 58.16 Mn
Dec 31, 2022 53.92 Mn
Sep 30, 2022 50.63 Mn
Jun 30, 2022 58.36 Mn
Mar 31, 2022 55.16 Mn
Dec 31, 2021 53.62 Mn
API Access

Alkermes Cost of Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=ALKS&period=max&api_key=YOUR_API_KEY